Abzena, a global partner research organization (PRO) specializing in the integrated development and manufacture of complex biologics and bioconjugates, has said that the location of its new GMP manufacturing facility will be Sanford, NC.   The significant expansion of Abzena’s capacity is driven by an increase in customer demand for commercial scale 2000L single use bioreactors across a wide range of therapeutic areas. Sanford will be Abzena’s sixth site in a global network providing integrated ...